Liquid biopsy for therapy monitoring in early-stage non-small cell lung cancer

Liquid biopsy is now considered a valuable diagnostic tool for advanced metastatic non-small cell lung cancer (NSCLC). In NSCLC, circulating tumor DNA (ctDNA) analysis has been shown to increase the chances of identifying the presence of targetable mutations and has been adopted by many clinicians o...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagasaka, Misako, Uddin, Mohammed Hafiz, Al-Hallak, Mohammed Najeeb, Rahman, Sarah, Balasubramanian, Suresh, Sukari, Ammar, Azmi, Asfar S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170728/
https://www.ncbi.nlm.nih.gov/pubmed/34074295
http://dx.doi.org/10.1186/s12943-021-01371-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170728/
https://www.ncbi.nlm.nih.gov/pubmed/34074295
http://dx.doi.org/10.1186/s12943-021-01371-1

Ejemplares similares